Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0022716 (
Menkes
)
1,057
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
The cDNA, coding for the first metal-binding domain (
MBD1
) of
Menkes
protein, was cloned into the T7-system based vector, pCA. The T7 lysozyme-encoding plasmid, pLysS, is shown to be crucial for expression, suggesting that the protein is toxic to the cells. Adding copper to the growth medium did not affect the plasmid stability.
MBD1
is purified in two steps with a typical yield of 12 mg.L-1.
Menkes
protein, a P-type ATPase, contains a sequence GMXCXSC that is repeated six times, at the N-terminus. The paired cysteine residues are involved in metal binding.
MBD1
has only two cysteine residues, which can exist as free thiol groups (reduced), as a disulphide bond (oxidized) or bound to a metal ion [e.g. Cu(I)-
MBD1
]. These three
MBD1
forms have been investigated using CD. No major spectral change was seen between the different
MBD1
forms, indicating that the folding is not changed upon metal binding. A copper-bound
MBD1
was also studied by EPR, and the lack of an EPR signal suggests that the oxidation state of copper bound to
MBD1
is Cu(I). Cu(I) binding studies were performed by equilibrium dialysis and revealed a stoichiometry of 1 : 1 and an apparent Kd = 46 microM. Oxidized
MBD1
, however, is not able to bind copper. Different copper complexes were investigated for their ability to reconstitute apo-
MBD1
. Given the same total copper concentration CuCl43- was superior to Cu(I)-thiourea (structural analogue of metallothionein) and Cu(I)-glutathione (used at fivefold higher copper concentration) although the latter two were able to partially reconstitute apo-
MBD1
. Cu(II) was not able to reconstitute apo-
MBD1
, presumably due to Cu(II)-induced oxidation of the thiol groups. Based on our results, glutathione and/or metallothionein are likely candidates for the in vivo incorporation of copper to
Menkes
protein.
...
PMID:Expression, purification and copper-binding studies of the first metal-binding domain of Menkes protein. 1049 Nov 37